Saturday, October 3, 2026

AI systems now execute cryptocurrency payments, influence US military strikes on Iran

MoonPay launched autonomous payment agents on February 24, 2026, while Claude AI helps prioritize US strike targets in Iran. The shift from question-answering chatbots to action-executing agents is accelerating across financial services, military operations, and healthcare in Q1 2026.

AI systems now execute cryptocurrency payments, influence US military strikes on Iran
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

MoonPay launched autonomous payment agents on February 24, 2026, enabling AI systems to execute cryptocurrency transactions without human approval. Claude AI is simultaneously helping US forces identify and prioritize strike targets in Iran, MIT Technology Review reported.

The deployment marks a global transition from chatbots that answer questions to agents that take action. "Companies have AI that can answer questions, but not AI that can act," said MoonPay's Murali Swaminathan.

Three agent categories are emerging across international markets: financial agents executing transactions, tactical agents recommending military actions, and workflow agents automating professional services. Rad AI's healthcare system makes scheduling decisions for radiologists without human intervention.

Enterprise adoption requires new infrastructure unavailable in most markets. AI agents need API integrations, permission frameworks limiting action scope, and audit trails tracking autonomous decisions. These differ from text-generating chatbots deployed globally since 2022.

The shift changes development priorities worldwide. Traditional large language models optimize for accuracy and knowledge retrieval. Autonomous agents require decision-making frameworks and safety constraints preventing unintended consequences.

Liability questions remain unresolved across jurisdictions. When AI agents execute payments or influence military strikes, accountability frameworks must determine responsibility for autonomous decisions. Current regulations in the US, EU, and Asia treat AI as advisory tools, not decision-making entities.

Investment is flowing toward agentic platforms. MoonPay Agents targets developers building AI applications interacting with financial systems, creating a category beyond conversational AI tools dominating markets since ChatGPT's 2022 launch.

Q1-Q2 2026 will test global enterprise appetite for autonomous agents versus traditional chatbots. Early adoption in US military operations and international payment systems suggests high-stakes domains are moving fastest, despite greater risks and regulatory uncertainty across borders.


Sources:
1 Yahoo Finance, "Commotion Launches Enterprise AI Operating System Powered by NVIDIA Nemotron™ Open Models to Scale P" (February 23, 2026)
2 Yahoo Finance, "This Nuclear Energy Trend Could Be Bigger Than Investors Think in 2026" (March 21, 2026)
3 Nasdaq, "1 Artificial Intelligence (AI) Stock That Could Be Worth a Fortune by 2030" (March 21, 2026)
4 Yahoo Finance, "History says these 2 overlooked asset classes are the only real shield against 1970s-style stagflati" (March 21, 2026)
5 Yahoo Finance, "Nadella paid $650M to recruit his AI chief. After 2 years he's quietly pushing him aside — these bru" (March 21, 2026)

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com